[et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Popup – #undefined” _builder_version=”4.7.4″ background_image=”https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/03\/investor-banner.jpg” parallax=”on” saved_tabs=”all” collapsed=”off” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][et_pb_fullwidth_header title=”Investor Information” header_fullscreen=”on” button_one_url=”#visionvalues” button_two_url=”#codeofconduct” _builder_version=”4.7.4″ title_font=”|700|||||||” title_text_color=”#f7941e” title_font_size=”40px” title_line_height=”1.2em” content_font=”||||||||” content_text_color=”#000000″ content_line_height=”1.8em” subhead_font=”||||||||” subhead_text_color=”rgba(0,0,0,0.6)” subhead_font_size=”22px” subhead_line_height=”1.4em” background_color=”rgba(255,255,255,0.7)” custom_button_one=”on” button_one_text_size=”20px” button_one_text_color=”#ffffff” button_one_bg_color=”#f7941e” button_one_border_width=”0px” button_one_font=”|||on|||||” button_one_use_icon=”off” custom_button_two=”on” button_two_text_size=”20px” button_two_text_color=”rgba(0,0,0,0.7)” button_two_bg_color=”#ffffff” button_two_border_width=”0px” button_two_font=”|||on|||||” button_two_use_icon=”off” button_two_custom_margin=”||||false|false” button_two_custom_margin_tablet=”” button_two_custom_margin_phone=”|||1px|false|false” button_two_custom_margin_last_edited=”on|desktop” button_two_custom_padding=”||||false|false” background_layout=”light” width=”50%” width_tablet=”” width_phone=”100%” width_last_edited=”on|phone” animation_style=”fade” animation_duration=”500ms” animation_delay=”300ms” title_font_tablet=”” title_font_phone=”” title_font_last_edited=”on|phone” content_font_tablet=”” content_font_phone=”” content_font_last_edited=”on|phone”]At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Popup – #undefined” _builder_version=”4.7.4″ background_enable_color=”off” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][et_pb_row _builder_version=”4.7.4″ width=”90%” max_width=”2560px” custom_padding=”0px||||false|false”][et_pb_column type=”4_4″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_font=”|600|||||||” header_font=”|700|||||||” header_text_color=”#f7941e” header_font_size=”25px” header_line_height=”1.2em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em” custom_margin=”||0px||false|false”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.7.4″ width=”90%” max_width=”2560px” custom_padding=”0px||0px||true|false”][et_pb_column type=”1_2″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_font=”|600|||||||” header_font=”|600|||||||” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em” custom_margin=”||0px||false|false”]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||”]<\/p>\n
A global commitment towards quality and patients<\/a><\/p>\n Download Notice of the 53rd Annual General meeting<\/a><\/p>\n Download Proxy Form and Attendance Slip<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_font=”|600|||||||” header_font=”|600|||||||” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em” custom_margin=”||0px||false|false”]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||”]<\/p>\n 1. Ranbaxy Drugs Limited<\/a><\/p>\n 2. Gufic Pharma Limited<\/a><\/p>\n 3. Vidyut Investments Limited<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.7.4″ width=”90%” max_width=”2560px” custom_padding=”||0px||false|false”][et_pb_column type=”4_4″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_font=”|600|||||||” header_font=”|600|||||||” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.7.4″ width=”90%” max_width=”2560px” custom_padding=”0px||0px||true|false”][et_pb_column type=”1_3″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||”]<\/p>\n 1. Ranbaxy Malaysia Sdn. Bhd., Malaysia<\/a><\/p>\n 2. Basics GmbH, Germany<\/a><\/p>\n 3. Ranbaxy GmbH, Germany<\/a><\/p>\n 4. Ranbaxy (S.A.) (Proprietory), South Africa<\/a><\/p>\n 5. Sonke Pharmaceuticals (Pty) Ltd.<\/a><\/p>\n 6. Ranbaxy Egypt (L.L.C.), Egypt<\/a><\/p>\n 7. Rexcel Egypt (L.L.C.), Egypt<\/a><\/p>\n 8. Ranbaxy (U.K.) Ltd., United Kingdom<\/a><\/p>\n 9. Ranbaxy Poland S.P. Z.o.o., Poland<\/a><\/p>\n 10. Ranbaxy Nigeria Ltd., Nigeria<\/a><\/p>\n 11. Ranbaxy (Thailand) Company Limited, Thailand<\/a><\/p>\n 12. Ranbaxy Pharmaceuticals Ukraine LLC, Ukraine<\/a><\/p>\n 13. Ranbaxy Morocco LLC, Morocco<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||”]<\/p>\n 14. Ranbaxy Farmaceutica Ltda., Brazil<\/a><\/p>\n 15. Ranbaxy PRP (Peru) S.A.C., Peru<\/a><\/p>\n 16. Ranbaxy Europe Ltd., United Kingdom<\/a><\/p>\n 17. R INC Consol 31 March 14<\/a><\/p>\n 18. Ranbaxy Pharmaceutical, Inc. USA<\/a><\/p>\n 19. Ranbaxy USA, Inc., USA<\/a><\/p>\n 20-Ohm Laboratories Inc., USA<\/a><\/p>\n 21. Ranbaxy Laboratories Inc., USA<\/a><\/p>\n 22. Ranbaxy Signature LLC, USA<\/a><\/p>\n 23. Ranbaxy (Netherlands) B.V. (\u201cRNBV\u201d), The Netherlands<\/a><\/p>\n 24. Ranbaxy Holdings (U.K.)<\/a><\/p>\n 25. Ranbaxy Ireland Ltd., Ireland<\/a><\/p>\n 26. ZAO Ranbaxy, Russia<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||”]<\/p>\n 27. Ranbaxy Pharmacie Generiques SAS, France<\/a><\/p>\n 28. Ranbaxy Portugal \u2013 Com E Desenvolv De Prod Farmaceuticos Unipessoal Lda, Portugal<\/a><\/p>\n 29. Laboratorios Ranbaxy, S.L., Spain<\/a><\/p>\n 30. Office Pharmaceutique Industriel Et Hospitalier SARL (\u201cOPIH SARL\u201d), France<\/a><\/p>\n 31. Ranbaxy Australia Pty. Ltd., Australia<\/a><\/p>\n 32. Ranbaxy Pharmaceuticals Canada Inc., Canada<\/a><\/p>\n 33. Ranbaxy Italia S.p.A Italy<\/a><\/p>\n 34. Terapia S.A., Romania<\/a><\/p>\n 35. Ranbaxy Belgium N.V., Belgium<\/a><\/p>\n 36. Be-Tabs Investments (Proprietary) Ltd., South Africa<\/a><\/p>\n 37. Be-Tabs Pharmaceuticals (Proprietary) Ltd., South Africa<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.7.4″ _module_preset=”default” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.7.4″ _module_preset=”default” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Popup – #undefined” _builder_version=”4.7.4″ background_color=”#f2f2f2″ da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on” da_disable_devices=”off|off|off”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.7.4″ width=”90%” max_width=”2560px” custom_padding=”0px||0px||true|false”][et_pb_column type=”1_2″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n Building for the Future<\/a><\/p>\n Download Notice of the 52nd Annual General meeting<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n Consolidate. Strengthen. Grow<\/a><\/p>\n Download Notice of the 51st Annual General meeting<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n 50 Years of evolution. The start of a revolution<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n New Boundaries. New Horizons.<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n The Energy of Synergy<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.4.2″][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n Focused on today\u2026 Poised for tomorrow\u2026<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n Towards Global Leadership<\/a>[\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n Vision beyond tomorrow<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\n Destination Discovery\u2026<\/a><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.7.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|700|||||||” header_3_text_color=”#000000″ header_3_font_size=”20px” header_3_line_height=”1.4em”]<\/p>\nAnnual Report\u00a0of India Subsidiary Companies\u00a0<\/strong>2013-14<\/h3>\n
Annual Report\u00a0of Overseas Subsidiary Companies\u00a0<\/strong>2013-14<\/h3>\n
Annual Report 2012<\/strong><\/h3>\n
Annual Report 2011<\/strong><\/h3>\n
Annual Report 2010<\/strong><\/h3>\n
Annual Report 2009<\/strong>
<\/a><\/h3>\nAnnual Report 2008<\/strong><\/h3>\n
Annual Report 2007<\/strong><\/h3>\n
Annual Report 2006<\/strong><\/h3>\n
Annual Report 2005<\/strong><\/h3>\n
Annual Report 2004<\/strong><\/h3>\n
Annual Report 2003<\/strong><\/h3>\n